Investors didn't show much interest in one Moderna way or another today. It hasn't moved too much today but is slightly down, it lost -0.94% since yesterday.
It looks like Moderna isn't currently at a very decisive point in regards to support/resistance levels. Moderna hasn't been looking too hot recently, some shareholders have been dumping shares over the last few months which has been driving prices down. In the past 3 months, the asset has lost -52.86 of it's value. So it's not looking great, I'd probably wait for a clearer support level before coming in. MRNA might find some support at the 99.6 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts are pretty neutral on Moderna right now, so not much useful information here. The current Analysts Sentiment Score is 5.85. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. On 2024-05-07 UBS Group increased their price target by 5.59% to $151.00. Oppenheimer gave a boost to their price target and moved to $163.00 from $142.00 on 2024-05-03. Royal Bank of Canada gave a boost to their price target and moved to $135.00 from $125.00 on 2024-05-03. On 2024-05-03 Canaccord Genuity Group increased their price target by 16.48% to $106.00. Needham & Company LLC announced that they are reiterating a rating of Hold on 2024-05-02. Jefferies Financial Group reiterated a rating of Buy on 2024-04-09 and provided a price target of $125.00. William Blair reiterated a rating of Market Perform on 2024-04-01. HSBC announced that they are reiterating a rating of Hold on 2024-02-26 and moved up their price target to $86.00 which is a 14.67% increase. JPMorgan Chase & Co. provided a price target decease of -3.23% to $90.00 from $93.00 on 2023-12-01. On 2023-11-03 The Goldman Sachs Group lowered their price target by -14.13% to $231.00.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| MRNA | 5.85 | 8.1 | -6.88 | 12.95 | -2.47 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| MRNA | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| MRNA | 4.94 | %5.5 | 4.5 | -1.914 | 18050000 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| MRNA |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BNTX | BioNTech SE American Depo | 1.9 | -4.00 | -1.37 | -8.58 | 15.80 | 3.17 | 5.13 | 49 | 18.98 | 12.62 | 20.59 | -10565.32 | -8853.94 | 0 | 0 | 1.88302 |
| NVAX | Novavax Inc | 1.05 | 0.75 | 11.63 | -18.75 | -27.58 | -46.80 | 50.65 | 23 | -7.16 | -5.43 | 1.69 | -5296.36 | -9552.39 | 0 | 150 | 23.8911 |
| ARCT | Arcturus Therapeutics Hol | 0.56 | -10.47 | -11.83 | -14.89 | -22.41 | -48.19 | -29.51 | 66 | -80.37 | -47.93 | -57.21 | -20122.16 | -2807.09 | 0 | 0 | 17.9767 |
| CTLT | CATALENT, INC. | 0.54 | 0.20 | 0.15 | -0.84 | -1.34 | 7.96 | 48.09 | 50 | 4.26 | 26.39 | 43.41 | -2002.89 | -54.01 | 0 | 0 | 4.97129 |
| RGEN | Repligen Corp | 0.53 | 8.10 | -2.48 | 2.75 | -4.49 | -12.52 | -11.53 | 62 | -8.98 | -11.04 | -18.74 | 301.84 | -4281.96 | 0 | 0 | 11.9373 |
| CVAC | CureVac N.V. Ordinary Sha | 0.53 | -0.40 | -6.74 | -8.46 | -22.43 | -37.28 | -54.64 | 49 | -96.46 | -51.98 | -61.64 | -29994.60 | -2435.23 | 0 | 0 | 6.97988 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
